AstraZeneca Vietnam was honored in the top 100 Best Places to Work for the 7th time

Vinh Phú |

AstraZeneca Vietnam continues to be honored in the "Top 100 Best Places to Work in Vietnam", holding the Top 4 position in the entire Pharmaceutical/Health Equipment/Health Care industry.

This is the 7th consecutive year since 2018, demonstrating AstraZeneca's commitment to sustainability in creating a working environment with people at the center, diverse and innovative.

AstraZeneca Vietnam constantly invests in developing a talented and diverse workforce, while nurturing a culture of learning, innovation and empowerment. The working environment here inspires each individual to overcome their own limits, contributing to the common goal of promoting scientific progress for public health.

At the ceremony, Mr. Atul Tandon, General Director of AstraZeneca Vietnam, shared: We appreciate this recognition as a testament to the continuous efforts of the AstraZeneca Vietnam team in building an open, cooperative and empowering working environment.

For more than 30 years of accompanying Vietnam, we have always aimed to improve the lives of patients, support the development of the health system, and contribute to the country towards a green and sustainable future, in line with the common commitment to Net Zero. This is the motivation for us to continue to create practical values for people and society.

Vinh Phú
TIN LIÊN QUAN

AstraZeneca Vietnam's Hanoi office receives LEED Gold certificate

|

On August 21, AstraZeneca Vietnam was awarded LEED Gold certificate by the US Green Building Council (USGBC) for its new office in Hanoi, marking an important step forward in the company's sustainable development strategy and long-term commitment in Vietnam. In more than 30 years of operation in Vietnam, AstraZeneca has accompanied the health sector to bring advanced health care solutions to the community. AstraZeneca Vietnam is the first inventive pharmaceutical company in Vietnam to be awarded LEED Gold certificate.

AstraZeneca was honored in the Top 50 Sustainable Development Enterprises in 2025

|

On July 15, at the announcement ceremony of the Top 50 Sustainable Development Enterprises in 2025 organized by Nhip Cau Tu Magazine, AstraZeneca Vietnam was honored in the category of Outstanding CSR Activities (Social Responsibility of Enterprises).

AstraZeneca organizes a series of scientific seminars on hereditary cancer

|

In order to improve the quality of treatment and health care for cancer patients in Vietnam, especially patients with genetic factors, AstraZeneca Vietnam Co., Ltd. accompanies frontline medical facilities in training to carry out a series of scientific activities: Conference "Oncology" of Bach Mai Hospital on June 14, 2025; Scientific workshop with Ho Chi Minh City Oncology Hospital and Cho Ray Hospital on June 20, 2025; deploy intensive extracurricular training on genetic consultation within the framework of a memorandum of understanding on cooperation with Ho Chi Minh City University of Medicine and Pharmacy on June 21, 2025.

AstraZeneca Vietnam's Hanoi office receives LEED Gold certificate

Vinh Phú |

On August 21, AstraZeneca Vietnam was awarded LEED Gold certificate by the US Green Building Council (USGBC) for its new office in Hanoi, marking an important step forward in the company's sustainable development strategy and long-term commitment in Vietnam. In more than 30 years of operation in Vietnam, AstraZeneca has accompanied the health sector to bring advanced health care solutions to the community. AstraZeneca Vietnam is the first inventive pharmaceutical company in Vietnam to be awarded LEED Gold certificate.

AstraZeneca was honored in the Top 50 Sustainable Development Enterprises in 2025

Vinh Phú |

On July 15, at the announcement ceremony of the Top 50 Sustainable Development Enterprises in 2025 organized by Nhip Cau Tu Magazine, AstraZeneca Vietnam was honored in the category of Outstanding CSR Activities (Social Responsibility of Enterprises).

AstraZeneca organizes a series of scientific seminars on hereditary cancer

Vinh Phú |

In order to improve the quality of treatment and health care for cancer patients in Vietnam, especially patients with genetic factors, AstraZeneca Vietnam Co., Ltd. accompanies frontline medical facilities in training to carry out a series of scientific activities: Conference "Oncology" of Bach Mai Hospital on June 14, 2025; Scientific workshop with Ho Chi Minh City Oncology Hospital and Cho Ray Hospital on June 20, 2025; deploy intensive extracurricular training on genetic consultation within the framework of a memorandum of understanding on cooperation with Ho Chi Minh City University of Medicine and Pharmacy on June 21, 2025.